Preparing for HPV vaccination in South Africa: Key challenges and opinions

Vaccine

Volumn 27, Issue 1, 2009, Pages 38-44

  Harries, Jane ^a   Moodley, Jennifer ^a   Barone, Mark A ^b   Mall, Sumaya ^a   Sinanovic, Edina ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ENGENDERHEALTH   (United States)

Author keywords

Cervical cancer; Cervical cancer prevention; Health service intervention; HPV vaccine; Human papillomavirus (HPV); Immunization; South Africa

Indexed keywords

WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ARTICLE; CANCER PREVENTION; CANCER SCREENING; CONDYLOMA ACUMINATUM; DRUG COST; DRUG EFFICACY; DRUG SAFETY; GENDER; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNIZATION; INTERVIEW; PRIORITY JOURNAL; SEXUAL EDUCATION; SOCIAL SUPPORT; SOUTH AFRICA; UTERINE CERVIX CANCER; VACCINE PRODUCTION; WART VIRUS;

ATTITUDE TO HEALTH; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS AS TOPIC; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SOUTH AFRICA; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 56949090652     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.033     Document Type: Article

References (31)

1. Mqoqi N., Kellett P., Sitas F., and Musa J. Incidence of histologically diagnosed cancer in South Africa 1998-1999 (2004), National Cancer Registry of South Africa, Johannesburg
2. Lazcano-Ponce E.C., Moss S., de Ruiz P.A., Castro J.S., and Avila M.H. Cervical cancer screening in developing countries: Why is it ineffective? The case of Mexico. Arch Med Res 30 3 (1999) 240-250
3. Denny L. Cervical cancer: the South African perspective. Int J Gynaecol Obstet 95 1 (2006) S211-S214
4. Moodley J., Kawonga M., Bradley J., and Hoffman M. Challenges in implementing a cervical screening programme in South Africa. Cancer Detect Prev 30 4 (2006) 361-368
5. Fonn S., Bloch B., Mabina M., Carpenter S., Cronje H., and Maise C. Prevalence of pre cancerous lesions and cervical cancer in South Africa-a multi centre study. S Afr Med J 92 2 (2002) 148-156
6. Muñoz N., Castellsagué X., Berrington A., de González A.B., and Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 21 24 Suppl. 3 (2006) S1-S10
7. World Health Organization. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries (2006), World Health Organization, Geneva
8. Jacob M., Bradley J., and Barone M.A. HPV vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?. Sex Transm Dis 32 (2005) 635-640
9. Zimet G.D., Shew M.L., and Kahn J.A. Appropriate use of cervical cancer vaccine. Annu Rev Med 59 (2008) 223-236
10. Brabin L., Roberts S., Stretch R., Baxter D., Chambers G., Kitchener H., et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 336 7652 (2008) 1056-1058
11. Wright T., Bosch F., Franco E., Cuzick J., Schiller J., Garnett G., et al. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 24 3 (2006) 251-261
12. Ault K., and Reisinger K. Programmatic issues in the implementation of an HPV vaccination programme to prevent cervical cancer. Int J Infect Dis 11 2 (2007) S26-S28
13. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., and Allen B. Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine 24 3 (2006) 201-209
14. Giles M., and Garland S. A study of women's knowledge regarding HPV infection, cervical cancer and HPV vaccines in Australia. Aust NZ J Obstet Gynaecol 46 4 (2006) 311-315
15. Rosenthal D., Dyson S., Pitts M., and Garland S. Challenges to accepting a HPV vaccine: a qualitative study of Australian women. Women Health 45 2 (2007) 59-73
16. Noakes K., Yarwood J., and Salisbury D. Parental response to the introduction of a vaccine against HPV. Hum Vaccin 2 6 (2006) 243-248
17. Moreira E.D., Oliveira B.G., Ferraz F.M., Costa S., Costa Filho J.O., and Karic G. Knowledge and attitudes about human papillomavirus, pap smears and cervical cancer among young women in Brazil: implications for health education and prevention. Int J Gynecol Cancer 16 2 (2006) 599-603
18. Ogilvie G.S., Remple V.P., Marra F., Mcneil S.A., Naus M., Pielakk L., et al. Parental intention to have daughters receive the HPV vaccine. CMAJ 177 12 (2007) 1506-1512
19. Pitts M., and Clarke T. Human Papillomavirus infections and risks of cervical cancer: what do women know?. Health Educ Res 17 6 (2002) 706-714
20. Vanslyke J.G., Baum J., Plaza V., Otero M., Wheeler C., and Helitzer D.L. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res 18 5 (2008) 584-596
21. Mosavel M., and El-Shaarawi N. I have never heard that one": young girls' knowledge and perception of cervical cancer. J Health Commun 12 8 (2007) 707-719
22. Kane M.A., Sherris J., Coursaget P., Aguado T., and Cutts F. HPV vaccine use in the developing world. Vaccine 21 24 (2006) 132-139
23. National Board of Health, Danish Centre for Health Technology Assessment (2007). Reduction in the risk of cervical cancer by vaccination against HPV-a health technology assessment Danish Center for Health Technology Assessment 9 (1). www.dacehta.dk. Retrieved 17 August 2007.
24. World Health Organization. Making decisions about contraceptive introduction: a guide for conducting assessments to broaden contraceptive choice and improve quality of care (2002), World Health Organization, Geneva
25. Simmons R., Hall P., Diaz J., Diaz M., Fajans P., and Satia J. The strategic approach to contraceptive introduction. Stud Fam Plann 28 2 (1997) 79-94
26. Thomas C. HPV vaccines: bring me your daughters!. S Afr Med J 98 4 (2008) 259-261
27. Goldie S., Kohli M., Grima D., Wienstein M., Wright T., Bosch F., et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96 8 (2004) 604-615
28. Orner P., Harries J., Cooper D., Moodley J., Hoffman M., Becker J., et al. Challenges to microbicide introduction in South Africa. Soc Sci Med 63 4 (2006) 968-978
29. Dunkle K., Jewkes R., Brown H., Gray G., McIntryre J., and Harlow S. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet 363 9419 (2004) 1415-1421
30. Wright T., Van Damme P., Schmitt H.-J., and Meheus A. Chapter 14: HPV vaccine introduction in industrialized countries. Vaccine 24 3 (2006) 122-131
31. Waller J., and Wardle J. HPV vaccination in the UK. BMJ 336 7652 (2008) 1028-1029